Rappta Therapeutics Competitors and Similar CompaniesClear all

Rappta Therapeutics's competitors and similar companies include Infinity Pharmaceuticals, Exelixis and TRACON Pharmaceuticals.

	Rappta Therapeutics Rappta Therapeutics is a company that develops anti-cancer drugs.	Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.	Exelixis Exelixis is an oncology company that develops cancer treatments.	TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
Founding Date	Founding Date 2006	Founding Date 2000	Founding Date 1994	Founding Date 2006
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Helsinki, FI HQ	Locations Cambridge, US HQ	Locations Alameda, US HQ	Locations San Diego, US HQ
Employees	Employees 8	Employees 25	Employees 1,14712% decrease	Employees 268% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 726.1 k	Valuation ($) 8.2 b	Valuation ($) 279.4 k
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2.6m (FY, 2022)	Revenue (est.) $2.3b (FY, 2025)	Revenue (est.) $12m (FY, 2023)
Net income	Net income N/A	Net income ($44.4m) (FY, 2022)	Net income $782.6m (FY, 2025)	Net income ($3.6m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 10.6m	Total funding raised $ 106.6m	Total funding raised N/A	Total funding raised $ 41m